Literature DB >> 6329690

Deletions in immunoglobulin mu chains.

G Köhler, M J Potash, H Lehrach, M J Shulman.   

Abstract

Eight mutant hybridoma lines are described, which synthesize short immunoglobulin mu chains. Four internal deletions were mapped by Southern blot analysis. They are shown to remove DNA from either part or all of the first, and first and second, constant mu exons. The sizes of the deletions range between 0.6 and 5 kb, leaving an equal or unequal number of splice signals. Shorter mu RNA of one size was found irrespective of whether an exon was completely or only partially deleted. These results preclude exclusive 3' (constant region) to 5' (variable region) directional splicing of the mu RNA. No important signals seem to reside in the deleted DNA stretches affecting the transcription or the correct RNA splicing of the remaining exons. The internal mu protein deletions revealed unusual covalent light chain attachment demonstrating functional homology between the first (normally used) and fourth mu constant domain. The other mu protein deletions (10, 11, and 12 kd) involved neither gross DNA nor RNA lesions and are considered to be due to premature chain termination. Since secretion is found in most of the mutant IgM-producing lines, no single one of the four mu constant domains (including the C-terminal one which contains the so-called secretory piece) is necessary for secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6329690      PMCID: PMC553087          DOI: 10.1002/j.1460-2075.1982.tb01208.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins.

Authors:  S L Morrison
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Sequences of mouse immunoglobulin light chain genes before and after somatic changes.

Authors:  O Bernard; N Hozumi; S Tonegawa
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

3.  A complete immunoglobulin gene is created by somatic recombination.

Authors:  C Brack; M Hirama; R Lenhard-Schuller; S Tonegawa
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

4.  Assignment of genes for immunoglobulin kappa and heavy chains to chromosomes 6 and 12 in mouse.

Authors:  H Hengartner; T Meo; E Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

6.  DNA sequence of the constant gene region of the mouse immunoglobulin kappa chain.

Authors:  W Altenburger; P S Neumaier; M Steinmetz; H G Zachau
Journal:  Nucleic Acids Res       Date:  1981-02-25       Impact factor: 16.971

7.  Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line.

Authors:  M S Neuberger; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

8.  Murine heavy chain disease.

Authors:  S L Morrison
Journal:  Eur J Immunol       Date:  1978-03       Impact factor: 5.532

9.  Amino acid sequence of a mouse immunoglobulin mu chain.

Authors:  M Kehry; C Sibley; J Fuhrman; J Schilling; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

10.  Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells.

Authors:  S Hickman; S Kornfeld
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

View more
  43 in total

1.  The mechanism of mammalian gene replacement is consistent with the formation of long regions of heteroduplex DNA associated with two crossing-over events.

Authors:  J Li; L R Read; M D Baker
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Use of a small palindrome genetic marker to investigate mechanisms of double-strand-break repair in mammalian cells.

Authors:  J Li; M D Baker
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

3.  Evidence for biased holliday junction cleavage and mismatch repair directed by junction cuts during double-strand-break repair in mammalian cells.

Authors:  M D Baker; E C Birmingham
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  Mechanisms involved in targeted gene replacement in mammalian cells.

Authors:  J Li; M D Baker
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

5.  Incorporation of large heterologies into heteroduplex DNA during double-strand-break repair in mouse cells.

Authors:  Steven J Raynard; Mark D Baker
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

6.  Ectopic recombination within homologous immunoglobulin mu gene constant regions in a mouse hybridoma cell line.

Authors:  M D Baker; L R Read
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

7.  Gene repeat expansion and contraction by spontaneous intrachromosomal homologous recombination in mammalian cells.

Authors:  Leah R Read; Steven J Raynard; Ania Rukść; Mark D Baker
Journal:  Nucleic Acids Res       Date:  2004-02-20       Impact factor: 16.971

8.  Nascent DNA synthesis during homologous recombination is synergistically promoted by the rad51 recombinase and DNA homology.

Authors:  Maureen M Mundia; Vatsal Desai; Alissa C Magwood; Mark D Baker
Journal:  Genetics       Date:  2014-02-28       Impact factor: 4.562

9.  Testing predictions of the double-strand break repair model relating to crossing over in Mammalian cells.

Authors:  Erin C Birmingham; Shauna A Lee; Richard D McCulloch; Mark D Baker
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  High-frequency homologous recombination between duplicate chromosomal immunoglobulin mu heavy-chain constant regions.

Authors:  M D Baker
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.